Literature DB >> 8113154

Macrophages enhance binding of beta-VLDL and cholesterol ester accumulation in cultured aortic smooth muscle cells.

R E Rennick1, J H Campbell, G R Campbell.   

Abstract

The effect of macrophages on the uptake of beta-very low-density lipoprotein (beta-VLDL) by smooth muscle cells (SMC) expressing different morphological phenotypes was examined in culture. The SMC were grown alone and in co-culture with macrophages for four days, then incubated with different concentrations of 125I-beta-VLDL for 3 h at 4 degrees C or with 75 ug/ml beta-VLDL for 24 h at 37 degrees C. The binding of beta-VLDL to SMC at 4 degrees C was enhanced in the presence of macrophages irrespective of the phenotype expressed by SMC. This occurred through modification of the lipoprotein, since binding of re-isolated macrophage-conditioned beta-VLDL to SMC was 12.5 times that of fresh beta-VLDL. This modified form of beta-VLDL competed with fresh beta-VLDL for binding to SMC. Binding was inhibited in the presence of probucol, suggesting that an oxidative mechanism may be involved. The presence of macrophages also enhanced the accumulation of beta-VLDL-derived cholesterol in SMC. While most of this is a consequence of the enhanced binding, macrophages may also act directly on SMC to increase cholesterol accumulation, since the activity of acid cholesterol ester hydrolase and neutral cholesterol ester hydrolase in SMC was reduced in the presence of macrophages.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8113154     DOI: 10.1007/bf01744492

Source DB:  PubMed          Journal:  Heart Vessels        ISSN: 0910-8327            Impact factor:   2.037


  42 in total

Review 1.  Beyond cholesterol. Modifications of low-density lipoprotein that increase its atherogenicity.

Authors:  D Steinberg; S Parthasarathy; T E Carew; J C Khoo; J L Witztum
Journal:  N Engl J Med       Date:  1989-04-06       Impact factor: 91.245

2.  Vascular smooth muscle phenotype and growth behaviour can be influenced by macrophages in vitro.

Authors:  R E Rennick; J H Campbell; G R Campbell
Journal:  Atherosclerosis       Date:  1988-05       Impact factor: 5.162

3.  Studies on the radioiodination of very low density lipoprotein obtained from different mammalian species.

Authors:  N H Fidge; P Poulis
Journal:  Clin Chim Acta       Date:  1974-03       Impact factor: 3.786

4.  Role of triglyceride-rich lipoproteins and hepatic lipase in determining the particle size and composition of high density lipoproteins.

Authors:  G J Hopkins; P J Barter
Journal:  J Lipid Res       Date:  1986-12       Impact factor: 5.922

5.  Metabolism of atherogenic lipoproteins by smooth muscle cells of different phenotype in culture.

Authors:  J H Campbell; M F Reardon; G R Campbell; P J Nestel
Journal:  Arteriosclerosis       Date:  1985 Jul-Aug

6.  Isolation of low density lipoprotein from atherosclerotic vascular tissue of Watanabe heritable hyperlipidemic rabbits.

Authors:  A Daugherty; B S Zweifel; B E Sobel; G Schonfeld
Journal:  Arteriosclerosis       Date:  1988 Nov-Dec

7.  Aortic accumulation and plasma clearance of beta-VLDL and HDL: effects of diet-induced hypercholesterolemia in rabbits.

Authors:  A Daugherty; L G Lange; B E Sobel; G Schonfeld
Journal:  J Lipid Res       Date:  1985-08       Impact factor: 5.922

8.  Interaction between macrophages and aortic smooth muscle cells. Enhancement of cholesterol esterification in smooth muscle cells by media of macrophages incubated with acetylated LDL.

Authors:  O Stein; G Halperin; Y Stein
Journal:  Biochim Biophys Acta       Date:  1981-09-24

9.  The rabbit as an animal model of hepatic lipase deficiency.

Authors:  M A Clay; G J Hopkins; C P Ehnholm; P J Barter
Journal:  Biochim Biophys Acta       Date:  1989-04-03

10.  Cholesteryl ester synthesis in macrophages: stimulation by beta-very low density lipoproteins from cholesterol-fed animals of several species.

Authors:  R W Mahley; T L Innerarity; M S Brown; Y K Ho; J L Goldstein
Journal:  J Lipid Res       Date:  1980-11       Impact factor: 5.922

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.